FDAnews Drug Daily Bulletin

Pharma Blog Watch

July 23, 2014
A A
Drug Costs High But Still Better Than Alternatives (World of DTC Marketing Blog)
Fewer than 4 percent of patients use specialty drugs, but they account for 25 percent of total drug spending. “The impact of the specialty tier benefit design falls disproportionately on patients who are living with diseases and conditions that are serious and life-threatening,” said Marialanna Lee, Northeast Region state government affairs director for the Leukemia & Lymphoma Society. Blogger Richard A. Meyer explains.